juvenile dermatomyositis , JDM (Abkürzung)

For the most part juvenile dermatomyositis is the same as the adult form, but the relationship with cancer is far lower, or non-existent.

Our group of patients includes, as far as we know, the first case of hypogonadism associated with juvenile dermatomyositis.

There is a form of this disorder that strikes children, known as juvenile dermatomyositis (JDM).

Calcinosis cutis (deposition of calcium in the skin) is usually seen in juvenile dermatomyositis, not adult dermatomyositis.

Some diseased areas that include the appearance of mineralized tissues include atherosclerotic plaques, tumoral calcinosis, juvenile dermatomyositis, kidney and salivary stones.

Juvenile dermatomyositis (JDM) is an idiopathic inflammatory myopathy (IMM) of presumed autoimmune dysfunction resulting in muscle weakness among other complications.

It is used as a treatment for some autoimmune diseases, including rheumatoid arthritis, Juvenile dermatomyositis, psoriasis, psoriatic arthritis, lupus, Crohn's disease, and many forms of vasculitis, to name a few.

Moreover, microchimeric cells of maternal origin may be involved in the pathogenesis of a group of autoimmune diseases found in children, i.e. juvenile idiopathic inflammatory myopathies (one example would be juvenile dermatomyositis).

The Center for Pediatric and Adolescent Rheumatology treats children and adolescents with rheumatic diseases including juvenile idiopathic arthritis, but also systemic lupus erythematosus, juvenile dermatomyositis, scleroderma and other connective tissue disorders.